CorWave appoints Jim Schuermann as an independent director

CorWave, a medtech company focused on the development of an innovative left ventricular assist device (LVAD), has announced today the election of Jim Schuermann to its board of directors. A press release states that Schuermann was instrumental in transforming HeartWare—a LVAD start-up valued around $100M when he joined—into a $Bn Nasdaq-listed company. As senior [...]